Atypical Fibrodysplasia Ossificans Progressiva Without Great Toe Malformation: A Diagnostic Challenge Preventing Unnecessary Surgical Intervention
- 23 April 2026
- journal article
- case report
- Published by Wolters Kluwer Health in Techniques in Foot & Ankle Surgery
- Vol. 25 (2)
Abstract
Fibrodysplasia ossificans progressiva (FOP) is an exceptionally rare and disabling genetic disorder clinically characterized by malformed great toes and progressive heterotopic ossification of soft tissues. Diagnosis of FOP requires generic confirmation by the presence of ACVR1 mutation. We describe the case of a 12-year-old girl who presented without malformed great toes but developed restricted hip movement after minor trauma, followed by soft tissue swelling and impaired mobility of the lumbar spine, cervical spine, and shoulders several months later. Radiographic imaging revealed heterotopic ossification adjacent to the left greater trochanter, without underlying skeletal abnormalities. Genetic analysis confirmed a heterozygous pathogenic mutation in the ACVR1 gene (c.617G>A, p.Arg206His). The diagnosis of FOP prompted reconsideration of the previously planned surgery for hip stiffness relief, given the known risk that surgical procedures may trigger disease flare-ups and additional heterotopic ossification. During follow-up, the patient experienced recurrent flare-ups characterized by localized swelling, which responded well to high-dose corticosteroid therapy and supportive anti-inflammatory management. Management focused on minimizing trauma, maintaining functional mobility, and avoiding invasive procedures known to exacerbate disease progression. Preventive strategies and timely intervention during flare-ups are essential to preserving the quality of life in affected individuals. This case highlights the importance of early clinical suspicion in atypical presentations of FOP, which may help clinicians avoid unnecessary surgical procedures that could potentially exacerbate heterotopic ossification. Early recognition and a multidisciplinary approach are essential for optimizing patient outcomes and preserving functional mobility. Level of Evidence: Diagnostic Level V. See Instructions for Authors for a complete description of levels of evidence.Keywords
This publication has 14 references indexed in Scilit:
- Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the ZebrafishJournal of Bone and Mineral Research, 2023
- Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organizationOrphanet Journal of Rare Diseases, 2021
- Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP)Developmental Biology, 2020
- Fibrodysplasia ossificans progressiva: a current review of imaging findingsSkeletal Radiology, 2018
- The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global AssessmentJournal of Bone and Mineral Research, 2015
- Multi‐system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1c.772G>A; R258G): A report of two patientsAmerican Journal of Medical Genetics Part A, 2015
- Fibrodysplasia Ossificans Progressiva: Clinical Course, Genetic Mutations and Genotype-Phenotype CorrelationMolecular Syndromology, 2014
- A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressivaNature Genetics, 2006
- The Phenotype of Fibrodysplasia Ossificans ProgressivaClinical & Translational Metabolism, 2005
- Conductive Hearing Loss in Individuals with Fibrodysplasia Ossificans ProgressivaAmerican Journal of Audiology, 1999